Page contentsPage contents Shortage information Key facts Key dates Related medicine information Shortage information The shortage affecting Tresiba has been resolved and the information and recommendations which were issued during the shortage no longer apply. Key facts Medicines affected Tresiba Supply shortage status Resolved International non-proprietary name (INN) or common name insulin degludec Therapeutic area (MESH) Diabetes Mellitus Pharmaceutical forms affected Pre-filled pen Strengths affected 100 units/ml 200 units/ml Availability of alternatives Yes Key dates First published 24/08/2023 Last updated 09/02/2026 Related medicine information Tresiba Information on shortages and national shortage registers Medicine Shortages Single Point of Contact (SPOC) Working Party National competent authorities (human) Share this page